- Home
- VCIG vs TOVX Comparison
VCIG vs TOVX Comparison
Compare VCIG & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCIG
- TOVX
- Stock Information
- Founded
- VCIG 2013
- TOVX 2001
- Country
- VCIG Malaysia
- TOVX United States
- Employees
- VCIG N/A
- TOVX N/A
- Industry
- VCIG Diversified Commercial Services
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- VCIG Consumer Discretionary
- TOVX Health Care
- Exchange
- VCIG Nasdaq
- TOVX Nasdaq
- Market Cap
- VCIG 5.3M
- TOVX 4.5M
- IPO Year
- VCIG 2023
- TOVX 2006
- Fundamental
- Price
- VCIG $1.23
- TOVX $0.50
- Analyst Decision
- VCIG
- TOVX Hold
- Analyst Count
- VCIG 0
- TOVX 1
- Target Price
- VCIG N/A
- TOVX N/A
- AVG Volume (30 Days)
- VCIG 6.4M
- TOVX 170.2K
- Earning Date
- VCIG 08-18-2025
- TOVX 08-12-2025
- Dividend Yield
- VCIG N/A
- TOVX N/A
- EPS Growth
- VCIG N/A
- TOVX N/A
- EPS
- VCIG 54.73
- TOVX N/A
- Revenue
- VCIG $27,819,290.00
- TOVX N/A
- Revenue This Year
- VCIG N/A
- TOVX N/A
- Revenue Next Year
- VCIG N/A
- TOVX N/A
- P/E Ratio
- VCIG $0.02
- TOVX N/A
- Revenue Growth
- VCIG 36.99
- TOVX N/A
- 52 Week Low
- VCIG $0.88
- TOVX $0.40
- 52 Week High
- VCIG $519.20
- TOVX $7.25
- Technical
- Relative Strength Index (RSI)
- VCIG 38.86
- TOVX 52.75
- Support Level
- VCIG $0.90
- TOVX $0.45
- Resistance Level
- VCIG $1.07
- TOVX $0.52
- Average True Range (ATR)
- VCIG 0.17
- TOVX 0.03
- MACD
- VCIG 0.06
- TOVX 0.01
- Stochastic Oscillator
- VCIG 43.75
- TOVX 77.78
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.